Science Explorer Back to mapMap
Discussion
Company · Cambridge · United States

Sarepta Therapeutics (United States)

In research, Sarepta Therapeutics (United States) stands highest in Biochemistry, Genetics and Molecular Biology (#3,223 of 5,801 worldwide) and Life Sciences (#6,770 of 11,023 worldwide), over all time. Relative to its size it is most specialised in Molecular Biology and Biochemistry, Genetics and Molecular Biology (Molecular Biology is 9.9× its share of world research).

World rank, 2022-now
#21,940
of 22,385 · #25,996 all time
Rank in United States
#3,255
of 3,332
Research works
314
▲ 102% vs 2018-21
Citations
11k
33.6 per fractional work
Top-10% rate
12.2%
all institutions 10.0%
vs its own fields
0.91×
1.00× is exactly expected
Open access
41%
world 40%
International
26%
world 18%

What is Sarepta Therapeutics (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Biochemistry, Genetics and Molecular BiologyField #3,223 of 5,801 12.6%136
Life SciencesDomain #6,770 of 11,023 13.1%161

Each strip is that field's whole ranked pool, with the notch where Sarepta Therapeutics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Sarepta Therapeutics (United States) work in?

In 2022-now, 43% of research at Sarepta Therapeutics (United States) is in Life Sciences, 37% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (39%), Medicine (36%), Economics, Econometrics and Finance (5%). It does 2.9× the world's share of Life Sciences.

Life Sciences: 54 fractional works · 43.5% of its workBiochemistry, Genetics and Molecular Biology: 48 fractional works · 38.8% of its workMolecular Biology: 37 fractional works · 29.8% of its workGenetics: 8 fractional works · 6.2% of its workCell Biology: 1 fractional works · 1.1% of its workClinical Biochemistry: 1 fractional works · 0.6% of its workCancer Research: 1 fractional works · 0.6% of its workBiotechnology: 1 fractional works · 0.4% of its workNeuroscience: 2 fractional works · 1.8% of its workCellular and Molecular Neuroscience: 2 fractional works · 1.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 2 fractional works · 1.5% of its workImmunology: 1 fractional works · 1.0% of its workParasitology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.9% of its workPlant Science: 1 fractional works · 0.4% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.5% of its workPharmaceutical Science: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.2% of its workHealth Sciences: 45 fractional works · 36.8% of its workMedicine: 44 fractional works · 35.6% of its workPhysiology: 7 fractional works · 5.5% of its workOncology: 5 fractional works · 4.2% of its workGenetics: 5 fractional works · 3.8% of its workCardiology and Cardiovascular Medicine: 4 fractional works · 2.9% of its workPulmonary and Respiratory Medicine: 3 fractional works · 2.3% of its workRheumatology: 2 fractional works · 2.0% of its workSurgery: 2 fractional works · 1.9% of its workEpidemiology: 2 fractional works · 1.5% of its workPsychiatry and Mental health: 2 fractional works · 1.3% of its workNeurology: 2 fractional works · 1.2% of its workInfectious Diseases: 1 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.1% of its workPharmacology: 1 fractional works · 1.0% of its workHealth Informatics: 1 fractional works · 0.8% of its workHepatology: 1 fractional works · 0.8% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.7% of its workPathology and Forensic Medicine: 1 fractional works · 0.6% of its workAnesthesiology and Pain Medicine: 1 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.4% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workNephrology: 0 fractional works · 0.3% of its workGastroenterology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 0.8% of its workHealth Information Management: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.2% of its workPhysical Sciences: 13 fractional works · 10.6% of its workChemistry: 5 fractional works · 4.3% of its workOrganic Chemistry: 3 fractional works · 2.8% of its workSpectroscopy: 1 fractional works · 1.1% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 4 fractional works · 3.2% of its workBiomedical Engineering: 4 fractional works · 3.2% of its workMaterials Science: 1 fractional works · 0.9% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 0.9% of its workInformation Systems: 0 fractional works · 0.4% of its workComputational Theory and Mathematics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 1 fractional works · 0.8% of its workStatistics and Probability: 1 fractional works · 0.8% of its workEnvironmental Science: 0 fractional works · 0.2% of its workEcology: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.0% of its workSocial Sciences: 11 fractional works · 9.1% of its workEconomics, Econometrics and Finance: 6 fractional works · 4.7% of its workEconomics and Econometrics: 6 fractional works · 4.7% of its workSocial Sciences: 2 fractional works · 2.0% of its workSociology and Political Science: 1 fractional works · 1.0% of its workEducation: 1 fractional works · 0.5% of its workCultural Studies: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 2 fractional works · 1.3% of its workManagement of Technology and Innovation: 1 fractional works · 0.8% of its workBusiness and International Management: 1 fractional works · 0.5% of its workPsychology: 1 fractional works · 0.7% of its workClinical Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workDecision Sciences: 1 fractional works · 0.4% of its workManagement Science and Operations Research: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 0 fractional works · 0.1% of its workALL ITS WORKSareptaTherapeutics…123fractional works, 2022-now
Life Sciences43%Physical Sciences11%Health Sciences37%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 23 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology4838.8%
    2. Neuroscience21.8%
    3. Immunology and Microbiology21.5%
    4. Agricultural and Biological Sciences10.9%
    5. Pharmacology, Toxicology and Pharmaceutics10.5%
    1. Medicine4435.6%
    2. Health Professions10.8%
    3. Veterinary00.2%
    4. Nursing00.2%
    1. Chemistry54.3%
    2. Engineering43.2%
    3. Materials Science10.9%
    4. Computer Science10.9%
    5. Mathematics10.8%
    6. Environmental Science00.2%
    7. Earth and Planetary Sciences00.2%
    8. Energy00.0%
    1. Economics, Econometrics and Finance64.7%
    2. Social Sciences22.0%
    3. Business, Management and Accounting21.3%
    4. Psychology10.7%
    5. Decision Sciences10.4%
    6. Arts and Humanities00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Sarepta Therapeutics (United States) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 9.9× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 36.7 works9.9×
  2. Biochemistry, Genetics and Molecular BiologyField · 47.8 works7.3×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.18× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.28× its world share, 48 worksBiochemistry, Geneti…Immunology and Microbiology: 1.50× its world share, 2 worksImmunology and Micro…Neuroscience: 1.11× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.34× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.71× its world share, 5 worksChemistryComputer Science: 0.12× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.13× its world share, 0 worksEarth and Planetary …Energy: 0.05× its world share, 0 worksEnergyEngineering: 0.22× its world share, 4 worksEngineeringEnvironmental Science: 0.05× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.27× its world share, 1 worksMaterials ScienceMathematics: 0.68× its world share, 1 worksMathematicsHealth Professions: 0.30× its world share, 1 worksHealth ProfessionsMedicine: 1.85× its world share, 44 worksMedicineNursing: 0.34× its world share, 0 worksNursingVeterinary: 1.76× its world share, 0 worksVeterinaryArts and Humanities: 0.03× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.39× its world share, 2 worksBusiness, Management…Decision Sciences: 0.43× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.18× its world share, 6 worksEconomics, Econometr…Psychology: 0.23× its world share, 1 worksPsychologySocial Sciences: 0.15× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.3×. Every wedge is a field page.

All 23 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology7.28×48 works
  2. Chemistry2.71×5 works
  3. Economics, Econometrics and Finance2.18×6 works
  4. Medicine1.85×44 works
  5. Veterinary1.76×0 works
  6. Immunology and Microbiology1.50×2 works
  7. Pharmacology, Toxicology and Pharmaceutics1.34×1 works
  8. Neuroscience1.11×2 works
  9. Mathematics0.68×1 works
  10. Decision Sciences0.43×0 works
  11. Business, Management and Accounting0.39×2 works
  12. Nursing0.34×0 works
  13. Health Professions0.30×1 works
  14. Materials Science0.27×1 works
  15. Psychology0.23×1 works
  16. Engineering0.22×4 works
  17. Agricultural and Biological Sciences0.18×1 works
  18. Social Sciences0.15×2 works
  19. Earth and Planetary Sciences0.13×0 works
  20. Computer Science0.12×1 works
  21. Energy0.05×0 works
  22. Environmental Science0.05×0 works
  23. Arts and Humanities0.03×0 works

Who are the top researchers at Sarepta Therapeutics (United States)?

Ranked on the quality score, Rachael A. Potter, Edward M. Kaye and Peter Sazani lead among researchers whose main affiliation is Sarepta Therapeutics (United States).

  1. 1 Rachael A. Potter United States · #416,214 worldwide 1.4k citations · 48 works
  2. 2 Edward M. Kaye United States · #494,137 worldwide 5.6k citations · 98 works
  3. 3 Peter Sazani United States · #642,178 worldwide 3.7k citations · 54 works
  4. 4 Patrick L. Iversen United States · #706,877 worldwide 12k citations · 300 works
  5. 5 Petra W. Duda United States · #802,059 worldwide 3k citations · 71 works
  6. 6 Jay S. Charleston United States · #998,863 worldwide 2.6k citations · 45 works
  7. 7 Damon R. Asher United States · #1,126,538 worldwide 916 citations · 35 works
  8. 8 Gunnar J. Hanson United States · #1,326,642 worldwide 1.4k citations · 54 works
  9. 9 Eddie Darton United States · #1,359,558 worldwide 407 citations · 16 works
  10. 10 Erin O’Rourke United States · #1,757,414 worldwide 902 citations · 51 works
All ranked researchers at Sarepta Therapeutics (United States)

What are the most cited papers from Sarepta Therapeutics (United States)?

The most cited paper from Sarepta Therapeutics (United States) is "Not So Different After All: A Comparison of Methods for Detecting Amino Acid Sites Under Selection" (Sergei L. Kosakovsky Pond, Simon D. W. Frost, 2005), with 2,510 citations. Next come "RNA therapeutics: beyond RNA interference and antisense oligonucleotides" (1,168) and "The trans-ancestral genomic architecture of glycemic traits" (918).

Most cited papers
#PaperReleasedCitations
1 Not So Different After All: A Comparison of Methods for Detecting Amino Acid Sites Under Selection Sergei L. Kosakovsky Pond, Simon D. W. Frost · Molecular Biology and Evolution 9 Feb 2005 2,510
2 RNA therapeutics: beyond RNA interference and antisense oligonucleotides Ryszard Kole, Adrian R. Krainer, Sidney Altman · Nature Reviews Drug Discovery ReviewOpen access 20 Jan 2012 1,168
3 The trans-ancestral genomic architecture of glycemic traits Jihua Chen et al. · Nature Genetics Open access417 authors 31 May 2021 918
4 Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study Sebahattin Çirak, Virginia Arechavala‐Gomeza, Michela Guglieri et al. · The Lancet Open access 25 Jul 2011 875
5 Eteplirsen for the treatment of Duchenne muscular dystrophy Jerry R. Mendell et al. · Annals of Neurology Open access Aug 2013 822
All 60 most cited papers, with filters and sorting

Which keywords describe research at Sarepta Therapeutics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Stem Cells, Muscle Regeneration, Skeletal Muscle Atrophy, Gene Therapy, Regenerative Medicine, Genomic Integration, Antisense Oligonucleotides and Cost-effectiveness Analysis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Stem Cells22▲ 65×4 topics
  2. Muscle Regeneration21▲ 619×1 topic
  3. Skeletal Muscle Atrophy21▲ 619×1 topic
  4. Epidemiology7▲ 1.51×30 topics
  5. Gene Therapy6▲ 28×3 topics
  6. Quality of Life5▲ 2.8×7 topics
  7. Regenerative Medicine5▲ 16×3 topics
  8. Genomic Integration5▲ 68×2 topics
  9. Treatment5▲ 3.2×13 topics
  10. Antisense Oligonucleotides5▲ 92×2 topics
  11. Clinical Trials5▲ 5.6×6 topics
  12. Cost-effectiveness Analysis4▲ 45×1 topic
  13. Health Utility Measures4▲ 45×1 topic
  14. AAV4▲ 87×1 topic
  15. Viral Vectors4▲ 87×1 topic
  16. Immunotherapy4▲ 4.6×6 topics
  17. Neuromuscular Junction4▲ 80×2 topics
  18. Patient Safety4▲ 21×3 topics
  19. Translational Research4▲ 91×2 topics
  20. Regulatory Challenges4▲ 37×1 topic
  21. SMN14▲ 149×1 topic
  22. Spinal Muscular Atrophy4▲ 149×1 topic
  23. Stem Cell Regulation4▲ 147×1 topic
  24. Genetic Mutations4▲ 7.3×8 topics
  25. Rehabilitation4▲ 8.0×3 topics
  26. Cancer Immunotherapy3▲ 18×2 topics
  27. CAR T Cells3▲ 35×1 topic
  28. Chimeric Antigen Receptor3▲ 35×1 topic
  29. Transcriptional Regulation3▲ 15×4 topics
  30. Biomechanics3▲ 7.5×2 topics
  31. Mitochondrial Dysfunction3▲ 7.3×6 topics
  32. Exoskeletons2▲ 63×1 topic
  33. Lower Limb2▲ 63×1 topic
  34. Epigenetic Regulation2▲ 9.2×3 topics
  35. Cell Proliferation2▲ 19×2 topics
  36. RNA Interference2▲ 21×1 topic
  37. siRNA Delivery2▲ 30×1 topic
  38. Arginine Methylation2▲ 63×1 topic
  39. Cardiomyopathies2▲ 55×1 topic
  40. Protein Arginine Methyltransferases2▲ 63×1 topic

Which research topics does Sarepta Therapeutics (United States) publish most on?

By volume in 2022-now: Muscle Physiology and Disorders, Health Systems, Economic Evaluations, Quality of Life, Virus-based gene therapy research and Neurogenetic and Muscular Disorders Research.

  1. 1 Muscle Physiology and Disorders Molecular Biology 21 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  3. 3 Virus-based gene therapy research Genetics 4 works
  4. 4 Neurogenetic and Muscular Disorders Research Genetics 4 works
  5. 5 Biomedical Ethics and Regulation Physiology 4 works
  6. 6 CAR-T cell therapy research Oncology 3 works
  7. 7 Prosthetics and Rehabilitation Robotics Biomedical Engineering 2 works
  8. 8 RNA Interference and Gene Delivery Molecular Biology 2 works
  9. 9 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 2 works
  10. 10 Cancer-related gene regulation Molecular Biology 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.1%not open58.9%

World: 40% of research is openly available.

with international co-authors26.2%domestic only73.8%

World: 18% is written across borders.

How has Sarepta Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 102% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Sarepta Therapeutics (United States) as a percentage of every work published that year, 0.00048% in 2024.

still counting0.00020%0.00040%0.00060%Sarepta Therapeutics (United States)0.00060% in 20251990200020102020

Fractional works of Sarepta Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Share Sarepta Therapeutics (United States)'s ranking

Sarepta Therapeutics (United States) on Science Explorer

A card with Sarepta Therapeutics (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Sarepta Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.